Bajos niveles de inhibidores de la coagulación: un factor de alto riesgo trombogénico en pacientes talasémicos

Gülhan, 2016, Effects of blood transfusion on cytokine profile and pulmonary function in patients with thalassemia major, Clin Respir J., 10, 153, 10.1111/crj.12193 Muncie, 2009, Alpha and beta thalassemia, Am Fam Physician., 80, 339 Cappellini, 2012, Hypercoagulability in β-thalassemia: A status quo, Expert Rev Hematol., 5, 505, 10.1586/ehm.12.42 Pignatti, 1998, Thromboembolic events in beta thalassemia major: An Italian multicenter study, Acta Haematol., 99, 76, 10.1159/000040814 Cappellini, 2000, Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia, Br J Haematol, 111, 467, 10.1046/j.1365-2141.2000.02376.x Eldor, 1999, A chronic hypercoagulable state in patients with β-thalassaemia major is already present in childhood, Br J Haematol, 107, 739, 10.1046/j.1365-2141.1999.01758.x Moawad, 2019, Platelet derived micro particles and the risk of pulmonary hypertension in Egyptian patients with thalassemia major, Researcher., 11, 62 Bhattacharyya, 2007, Hypercoagulable state in five thalassemia intermedia patients, Clin Appl Thromb Hemost., 13, 422, 10.1177/1076029607303539 Karmakar, 2016, Platelet proteomics in thalassemia: factors responsible for hypercoagulation, Proteomics Clin Appl, 10, 239, 10.1002/prca.201500049 Kumar, 2017, PAI-1 study in thalassemia major patients receiving multiple blood transfusion, Indian J Clin Biochem., 32, 343, 10.1007/s12291-016-0620-7 Hashemieh, 2015, The Iran thalassemia prevention program: Success or failure?, Iran J Pediatr Hematol Oncol, 5, 161 Abosdera, 2017, Coagulation defects in thalassemic patients, Pediatr Neonatol, 58, 421, 10.1016/j.pedneo.2016.07.009 Sipahi, 2009, Congenital thrombotic risk factors in β-thalassemia, Clin Appl Thromb Hemost, 15, 581, 10.1177/1076029608316170 Panah, 2010, Coagulation inhibitors in thalassemia, Sci J Iran Blood Transfus Organ., 2, 78 Karami, 2010, Assessment of coagulation state and its related factors in thalassemia intermedia patients referred to thalassemia research center at Booali Sina Hospital Sari/IR Iran in 2007, Pak J Biolog Sci, 13, 448, 10.3923/pjbs.2010.448.451 Elgammal, 2012, Plasma levels of soluble endothelial protein C-receptor in patients with β-thalassemia, Alex J Med., 48, 283, 10.1016/j.ajme.2011.10.007 Huang, 2018, Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin, Thromb Res., 172, 61, 10.1016/j.thromres.2018.10.016 Hassan, 2010, Protein C levels in β-thalassemia major patients in the east Nile delta of Egypt, Hemat Oncol Stem Cell Ther., 3, 60, 10.1016/S1658-3876(10)50036-0 Musumeci, 1987, Protein C and antithrombin III in polytransfused thalassemic patients, Acta Haematol., 77, 30, 10.1159/000205945 Eldor, 2002, The hypercoagulable state in thalassemia, Blood., 99, 36, 10.1182/blood.V99.1.36